{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T21:41:07Z","timestamp":1774734067727,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.pmr.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T09:04:25Z","timestamp":1425632665000},"page":"375-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Chronic Daily Headache"],"prefix":"10.1016","volume":"26","author":[{"given":"Natalia","family":"Murinova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Krashin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pmr.2015.01.001_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1526-4610.1996.3601014.x","article-title":"Analgesic rebound headache in clinical practice: data from a physician survey","volume":"36","author":"Rapoport","year":"1996","journal-title":"Headache"},{"issue":"21 Suppl","key":"10.1016\/j.pmr.2015.01.001_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0333102498018S2109","article-title":"Medication misuse headache","volume":"18","author":"Mathew","year":"1998","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.pmr.2015.01.001_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1526-4610.2009.01461.x","article-title":"From psychoneurosis to ICHD-2: an overview of the state of the art in post-traumatic headache","volume":"49","author":"Gladstone","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.pmr.2015.01.001_bib4","unstructured":"Willis T. De anima brutorum quae hominis vitalis ac sensitive est exercitationes duae. London, 1672. English version. Two discourses concerning the Soul of Brutes, which is that of the vital and Sensitive of Man. The Remaining Medical Works of that Famous and Renowned Physician Dr Thomas Willis, London. 1683:121\u20132."},{"issue":"1","key":"10.1016\/j.pmr.2015.01.001_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/head.12014","article-title":"An update on the management of chronic migraine","volume":"53","author":"Evans","year":"2013","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"9","key":"10.1016\/j.pmr.2015.01.001_bib6","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1526-4610.2006.00577.x","article-title":"Modifiable risk factors for migraine progression","volume":"46","author":"Bigal","year":"2006","journal-title":"Headache"},{"issue":"7 Suppl 2","key":"10.1016\/j.pmr.2015.01.001_bib7","first-page":"S37","article-title":"Chronic daily headache an evidence-based and systematic approach to a challenging problem","volume":"76","author":"Halker","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pmr.2015.01.001_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrneurol.2012.13","article-title":"Chronic migraine\u2014classification, characteristics and treatment","volume":"8","author":"Diener","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pmr.2015.01.001_bib9","first-page":"S37","article-title":"Shared mechanisms in affective illness, epilepsy, and migraine","volume":"44","author":"Post","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.pmr.2015.01.001_bib10","series-title":"Comorbidity in migraine","first-page":"96","article-title":"Migraine and medication overuse","author":"Silberstein","year":"2011"},{"issue":"2A","key":"10.1016\/j.pmr.2015.01.001_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1590\/S0004-282X2005000200005","article-title":"Depression in chronic migraine: severity and clinical features","volume":"63","author":"Mercante","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10.1016\/j.pmr.2015.01.001_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/head.12014","article-title":"A\u00a0rational approach to the management of chronic migraine","volume":"53","author":"Evans","year":"2013","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.pmr.2015.01.001_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The international classification of headache disorders, (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.pmr.2015.01.001_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp042897","article-title":"Chronic daily headache","volume":"354","author":"Dodick","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.pmr.2015.01.001_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"Onabotulinumtoxin A for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.pmr.2015.01.001_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11916-010-0159-x","article-title":"Treatment of chronic migraine","volume":"15","author":"Diener","year":"2011","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"10.1016\/j.pmr.2015.01.001_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2002.02122.x","article-title":"Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study","volume":"42","author":"Saper","year":"2002","journal-title":"Headache"},{"issue":"12","key":"10.1016\/j.pmr.2015.01.001_bib18","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/01.WNL.0000100121.58594.11","article-title":"Gabapentin in the prophylaxis of chronic daily headache. A randomized, placebo-controlled study","volume":"61","author":"Spira","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.pmr.2015.01.001_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1526-4610.2007.00949.x","article-title":"Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine","volume":"48","author":"Blumenfeld","year":"2008","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.pmr.2015.01.001_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10072-010-0268-7","article-title":"Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials","volume":"31","author":"D\u2019Amico","year":"2010","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.pmr.2015.01.001_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.pmr.2015.01.001_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clineuro.2010.02.004","article-title":"Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine","volume":"112","author":"Magalh\u00e3es","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"10.1016\/j.pmr.2015.01.001_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","article-title":"Double-blind trial of fluoxetine: chronic daily headache and migraine","volume":"34","author":"Saper","year":"1994","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.pmr.2015.01.001_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/WNF.0b013e3181bf1dbe","article-title":"Pregabalin in the treatment of chronic migraine: an open-label study","volume":"33","author":"Calandre","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.pmr.2015.01.001_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.wnf.0000150866.98887.77","article-title":"Open-label zonisamide for refractory migraine","volume":"27","author":"Drake","year":"2004","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.pmr.2015.01.001_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1526-4610.2002.02126.x","article-title":"Olanzapine in the treatment of refractory migraine and chronic daily headache","volume":"42","author":"Silberstein","year":"2002","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.pmr.2015.01.001_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1526-4610.2007.01016.x","article-title":"Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach?","volume":"48","author":"Spengos","year":"2008","journal-title":"Headache"},{"issue":"15","key":"10.1016\/j.pmr.2015.01.001_bib28","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1177\/0333102411420585","article-title":"Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial","volume":"31","author":"Yang","year":"2011","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.pmr.2015.01.001_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1526-4610.2002.02123.x","article-title":"Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years","volume":"42","author":"Grazzi","year":"2002","journal-title":"Headache"},{"issue":"14","key":"10.1016\/j.pmr.2015.01.001_bib30","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1177\/0333102411419681","article-title":"Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls","volume":"31","author":"Varkey","year":"2011","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.pmr.2015.01.001_bib31","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1468-2982.2008.01670.x","article-title":"Chronic daily headache in Brazil: a nationwide population-based study","volume":"28","author":"Queiroz","year":"2008","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.pmr.2015.01.001_bib32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1468-2982.2001.00307.x","article-title":"Melatonin in the preventive treatment of chronic cluster headache","volume":"21","author":"Peres","year":"2001","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.pmr.2015.01.001_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.wnl.0000323925.29520.e7","article-title":"Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.pmr.2015.01.001_bib34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/WNL.0b013e31824d5846","article-title":"Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.pmr.2015.01.001_bib35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1526-4610.2010.01687.x","article-title":"Suboccipital nerve blocks for suppression of chronic migraine: safety, efficacy, and predictors of outcome","volume":"50","author":"Weibelt","year":"2010","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.pmr.2015.01.001_bib36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jnnp.2007.124420","article-title":"Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study","volume":"79","author":"Ashkenazi","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"13","key":"10.1016\/j.pmr.2015.01.001_bib37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.0b013e318212ab1e","article-title":"Improvement of migraine headaches in severely obese patients after bariatric surgery","volume":"76","author":"Bond","year":"2011","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.pmr.2015.01.001_bib38","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/0333102411413162","article-title":"Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series","volume":"31","author":"Novack","year":"2011","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.pmr.2015.01.001_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/PRS.0b013e3181fed456","article-title":"Five-year outcome of surgical treatment of migraine headaches","volume":"127","author":"Guyuron","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.pmr.2015.01.001_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0333102410381142","article-title":"Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study","volume":"31","author":"Saper","year":"2011","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.pmr.2015.01.001_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1533-2500.2010.00412.x","article-title":"Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia","volume":"11","author":"Zhao","year":"2011","journal-title":"Pain Practice"},{"issue":"4","key":"10.1016\/j.pmr.2015.01.001_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10194-011-0348-y","article-title":"Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study","volume":"12","author":"Gaul","year":"2011","journal-title":"The journal of headache and pain"},{"issue":"7","key":"10.1016\/j.pmr.2015.01.001_bib43","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/01.WNL.0000052687.03646.74","article-title":"Why headache treatment fails","volume":"60","author":"Lipton","year":"2003","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.pmr.2015.01.001_bib44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1212\/WNL.0b013e31820d8af2","article-title":"Rates, predictors, and consequences of remission from chronic migraine to episodic migraine","volume":"76","author":"Manack","year":"2011","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.pmr.2015.01.001_bib45","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1526-4610.2006.00509.x","article-title":"From transformed migraine to episodic migraine: reversion factors","volume":"46","author":"Seok","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.pmr.2015.01.001_bib46","unstructured":"Shapiro R. Headache disorders. Pain in America: exploring challenges to relief. Testimony submitted to the United States Senate. Health, Education, Labor, and Pension Committee. Washington, DC. 2012;2(14):12."}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965115000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965115000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:38:12Z","timestamp":1760931492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965115000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1047965115000029"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2015.01.001","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Daily Headache","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}